Dall, Peter https://orcid.org/0000-0002-0565-7840
Hildebrandt, Thomas
du Bois, Andreas
Boetel, Eric
Ahlfaenger, Janine
Beckmann, Matthias W.
Bommert, Mareike
Article History
Received: 15 December 2019
Accepted: 28 March 2020
First Online: 18 April 2020
Compliance with ethical standards
:
: PD, TH, AdB, EB, JA, MWB and MB declare no conflict of interest related to this manuscript. AdB receiving advisory fees from AstraZeneca, Roche, Tesaro, Clovis, BioCad, Genmab, and Pfizer. MB reports non-financial support from prIME Oncology (travel support), outside the submitted work.
: All procedures performed in the survey involving human participants were in accordance with the ethical standards of institutional and national research committee (Ethic Committee of Friedrich Alexander University of Erlangen–Nuremberg). The study does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.